(Reuters) - Franklin Advisers Inc. and Templeton Asset Management Ltd. moved an Israeli court to restrain Taro from concluding any deal that could hurt minority interests.
As part of the court proceedings, Taro agreed to decrease the interim funding of $45 million by 9.5 percent, the Israeli generic drug maker said.
Read more at Reuters.com Mergers News
As part of the court proceedings, Taro agreed to decrease the interim funding of $45 million by 9.5 percent, the Israeli generic drug maker said.
Read more at Reuters.com Mergers News
No comments:
Post a Comment